⌕
Innoviva · INVA · Nasdaq
Tenet 74 · Solid
Compare
$19.03+0.32%At closeTenet 74 · Solid
$19.03+0.06 (+0.32%)
At close: Nov 13, 2026, 4:00 PM ET· Nasdaq · USD

Innoviva (INVA) Stock

Innoviva (INVA) closed at $19.03 on Nov 13, 2026; its Tenet Score is 74 of 100 against 409 Healthcare peers.

Sources Company filings, market prices and computed by Tenet Filings, prices and TenetScore as of How we compute thisNot investment advice

7 figures withheld by our checks. Each blank figure names its reason.

Key stats

Previous close
$19.03
Nov 13, 2026
Market cap
$1.4B
share price × the latest quarter's diluted weighted-average share count (vendor)
P/E
7.1×
price ÷ earnings
52-week range
18.66 – 25.14
low → high
Tenet Score
74/100
Solid · 409 Healthcare peers

Industry: Drugs · see every company filed here →

Innoviva Inc scores 74/100. Solid. Strongest on value and financial health, trading at 7× earnings versus 409 Healthcare peers.

Tenet Score · vs sector

n=409
74/ 100
Solid
Fundamental composite — rates the business, not the timing.
Each metric's standing vs the company's own record is shown on the Statistics tab.
Value
94
Quality
66
Health
76
Growth
59

Factor grades

Grid rings: 25 · 50 · 75 · 100 percentile
ValueAQualityCHealthBGrowthCMomentumD
A grade is a label over the shown score. Value/Quality/Health/Growth are sector percentiles; Momentum ranks 12−1 return across the equity universe — a lens, never folded into the Tenet Score.
Show the math →

Price

Loading chart…
P/B
1.2×
price to book value
P/S
3.1×
price to fiscal 2025 sales
ROE
18%
return on equity
Operating margin
39.8%
fiscal 2025, before interest and tax
Net margin
44.1%
of revenue kept
Current ratio
15.44
current assets to liabilities
Net debt / EBITDA
−1.6×
leverage, net of cash
EPS CAGR 5y
—
This growth figure starts in a period outside the history your plan includes.
Div yield
—
no yield on file

The whole report, at a glance · every card is a live peek, click any to open the section

About Innoviva Inc

Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled cortic…

Composite computed Nov 16, 2026 · peer basis: Healthcare (n=409) · every glimpse links to its full section with sources · not investment advice.

ETF exposure

held by 127 US ETFs · top wrappers by weightSee all ETFs holding INVA →

Similar-sized companies in Drugs

The 10 companies in this industry closest in market cap, as of Nov 13, 2026.

What sector and industry is Innoviva in?

Innoviva is in the Healthcare sector and the Drugs industry.

What is Innoviva's Tenet Score?

Innoviva's Tenet Score is 74 out of 100, ranked against 409 Healthcare peers as of Nov 16, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.